Synthetic opioids continue to concern European drug agencies. A new report states that ‘polydrug’ use is leading to new health risks. Data on cannabis since Germany’s legalization, however, is still sparse.

The top takeaway from the European Drug Report 2024
 : Drug users in Europe are increasingly using more than one drug at the same time a practice known as “polydrug” or “polysubstance” use. And synt…